U.S. Industrials Stock News

In recent weeks, Atlantic Union Bankshares held an investor day where management outlined a shift from capital investment to capital deployment starting in 2026, prompting multiple research firms to reaffirm or reiterate their views on the bank’s outlook. Analysts were particularly focused on the company’s growth plans and balance sheet repositioning, highlighting both the potential benefits of deploying excess capital and the challenges posed by lower yields and revised earnings...

In recent days, First Horizon Bank announced that experienced banker Justin Rutledge has joined as Charlotte Market President, while the parent company scheduled its fourth-quarter and full-year 2025 results release and investor call for January 15, 2026. Alongside these management and disclosure updates, a series of analyst rating changes and refreshed views on the stock have sharpened how the market assesses First Horizon’s prospects. We’ll now examine how the recent analyst sentiment...

In early December 2025, Amneal Pharmaceuticals announced FDA approval for its epinephrine injection USP 1 mg/mL in single- and multi-dose vials, a critical hospital and emergency therapy serving a U.S. market with around US$118 million in annual sales. Just days earlier, the company also reported encouraging interim Phase 4 ELEVATE-PD data for its CREXONT extended-release Parkinson’s therapy, underscoring progress in higher-value neurology treatments alongside its expanding injectables...

As the U.S. stock market rebounds with major indices like the Dow Jones and S&P 500 poised to break their recent losing streaks, investors are closely monitoring inflation trends that have come in lower than expected. In this environment of fluctuating economic indicators, identifying stocks that may be undervalued can offer potential opportunities for those looking to capitalize on discrepancies between current prices and perceived fair value.

Major stock indexes in the United States recently experienced a boost, with inflation data coming in cooler than anticipated, leading to a positive shift in market sentiment. For investors willing to explore beyond well-known companies, penny stocks—often associated with smaller or newer firms—continue to offer intriguing opportunities. Despite their vintage label, these stocks can provide growth potential at lower price points when backed by strong financials and solid fundamentals.

Essential Properties Realty Trust recently announced that Robert W. Salisbury, CFA will become Executive Vice President and Chief Financial Officer on January 1, 2026, succeeding outgoing CFO Mark E. Patten, who will resign at the end of 2025. This leadership transition brings a capital-markets-focused insider into the top finance role, a shift that could influence funding decisions, risk appetite and communication with investors. With Salisbury’s promotion to CFO set to reshape the finance...

In December 2025, California Resources Corporation’s Carbon TerraVault unit signed a non-binding Memorandum of Understanding with Middle River Power to become the exclusive provider of CO2 transportation and sequestration services for two California gas-fired power plants emitting up to 2.75 million metric tons of CO2 annually. This first agreement for a brownfield power facility in Northern California could help advance CRC’s carbon management ambitions and support the state’s wider...

BellRing Brands (BRBR) has quietly drifted lower this year, even as revenue and net income keep growing at mid single digit rates. That disconnect between fundamentals and share price is where things get interesting for investors. See our latest analysis for BellRing Brands. Despite that growth, the share price has been under pressure, with a sharp year to date share price loss and a similarly weak 1 year total shareholder return suggesting momentum has clearly faded as investors reassess how...

Recently, reports emerged that Google is testing homes-for-sale listings directly in its search results, raising questions about the long-term resilience of CoStar Group’s Homes.com-focused growth strategy amid ongoing legal disputes. At the same time, CoStar’s own analytics highlighted Charlotte as the top-performing large U.S. retail market in 2025, underscoring the company’s influence in shaping how investors and occupiers understand local property trends. We’ll now examine how the threat...

AGNC Investment (AGNC) just expanded its board and brought in former Voya Investment Management CEO Christine Hurtsellers, while reaffirming both common and preferred dividends. This combination puts governance and income stability in sharper focus. See our latest analysis for AGNC Investment. Those moves land against a backdrop of improving sentiment, with the 12.50% year to date share price return and a 30.23% one year total shareholder return suggesting that momentum in AGNC’s income...

In recent days, Citigroup Inc. has issued several fixed‑income securities totaling more than US$216 million, advanced its Banamex exit by selling a 25% stake to Mexican investor Fernando Chico Pardo, and won a UK court ruling that blocked a very large foreign‑exchange lawsuit alongside other major banks. Together with fresh analyst upgrades and commentary that its multi‑year restructuring is about two‑thirds complete, these moves reinforce investors’ perception that Citigroup’s...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps aimed squarely at pre clinical pharma and biotech workflows, a targeted move that could deepen its role in nucleic acid therapeutics discovery. See our latest analysis for Twist Bioscience. The launch of plasmid DNA preps and Twist’s upcoming presence at the Antibody Engineering and Therapeutics conference come as momentum starts to rebuild, with a 30 day share price return of 23.6 percent but a still negative one year...

Federal Signal (FSS) is drawing fresh attention after new data underscored its strong revenue trajectory and an expected pickup in demand, with earnings growth continuing to outpace sales and support the recent share price strength. See our latest analysis for Federal Signal. At a latest share price of $109.55, Federal Signal has eased off its recent highs after a softer 90 day share price return. That comes on top of an 18.75% year to date share price return and a 5 year total shareholder...

Unum Group (UNM) just rolled out a new share repurchase plan of up to $1 billion, a strong signal about how management views the stock, even as short interest has recently ticked higher. See our latest analysis for Unum Group. That confidence backed by the $1 billion buyback comes on top of a steady climb, with the share price at $77.91 and a solid year to date share price return. The three year and five year total shareholder returns suggest long term momentum is very much intact. If this...

Bitdeer Technologies Group recently reported unaudited operating results for November 2025, showing total hash rate under management of 60.3 EH/s, 264,000 mining rigs under management, and 526 bitcoins mined from self-mining, all sharply higher than a year earlier. The scale of this operational expansion effectively triples Bitdeer’s managed hash rate year-on-year, underscoring how rapidly its mining footprint has grown. Next, we’ll examine how this rapid hash rate expansion and higher...

UBS came away more constructive on Exponent (EXPO) after recent management meetings, highlighting improving demand for its proactive Consumer Electronics work and a planned build out of full time staff that could support stronger 2026 revenue. See our latest analysis for Exponent. That brighter narrative contrasts with a tougher stretch for investors, with the share price at $73.69 and a year to date share price return of minus 16.2 percent and a one year total shareholder return of minus...

TransUnion (TRU) just rolled out a major upgrade to its Device Risk fraud platform, leaning heavily into adaptive machine learning and cross session device identification at a time when fraud is quietly eroding corporate margins. See our latest analysis for TransUnion. The latest Device Risk upgrade lands at an interesting moment, with TransUnion’s share price at $84.75 after a 1 month share price return of 5.71% but a weaker year to date share price return of 7.73%. At the same time, the 3...

We wouldn't blame Dolby Laboratories, Inc. ( NYSE:DLB ) shareholders if they were a little worried about the fact that...

PENN Entertainment recently faced a patent infringement lawsuit from Single Action Bet Tech over alleged unauthorized use of single-action betting technology in its Hollywood Casino digital products, while also moving ahead with plans to introduce Jackpot Digital’s dealerless poker tables at its Mississippi properties following Jackpot’s licensing earlier this year. These developments highlight both PENN’s push to expand its digital and technology-enabled gaming offerings and the legal and...

Eli Lilly recently reported strong Phase 3 results for its next-generation obesity drugs, including the oral GLP‑1 pill orforglipron for weight maintenance and the triple‑agonist retatrutide for weight loss and knee osteoarthritis, while also expanding manufacturing capacity and advancing oncology assets like Inluriyo and Jaypirca. Together, these updates underline Lilly’s attempt to build a broad obesity and specialty medicine franchise that spans injectable and oral treatments, long-term...

Graphic Packaging Holding (GPK) has investors on alert after a one two punch of mixed quarterly results and a CEO transition, with long time leader Michael Doss set to hand the reins to Robbert Rietbroek. See our latest analysis for Graphic Packaging Holding. The leadership handover lands against a tough backdrop, with the latest share price at $15.53 and a steep year to date share price return of minus 42.01 percent. The five year total shareholder return is barely positive, signaling fading...

Earlier this month, Capricor Therapeutics announced positive topline Phase 3 HOPE-3 results for Deramiocel in Duchenne muscular dystrophy, alongside a planned patient-focused webinar and an exclusive commercialization and distribution agreement with Nippon Shinyaku for the US and Japan, all subject to regulatory approval. This combination of late-stage clinical success, regulatory engagement and a partnered commercialization path could be pivotal for Capricor’s transition from a...

Earlier in December 2025, AAON reported third-quarter results that exceeded its own revenue and earnings guidance, raised its full-year outlook on strong data center demand, and disclosed that Executive Vice President Stephen E Wakefield bought additional company stock worth about US$484,400. These developments, alongside a leadership promotion effective January 1, 2026 and a scheduled cash dividend, highlight both management’s confidence and AAON’s growing focus on high-demand end markets...

United Parks & Resorts’ fiscal Q3 2025 results, released earlier this year, fell short of expectations as revenue and earnings were hit by unfavorable calendar shifts, poor holiday weather, and softer international visitation that weighed on park attendance. Despite these headwinds, management highlighted stronger forward booking trends into 2026, particularly at Discovery Cove and in group business, suggesting that advance demand may be more resilient than the recent quarter implied. We’ll...